Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity.
Status:
Completed
Trial end date:
2021-03-25
Target enrollment:
Participant gender:
Summary
This study will look at the change in body weight in people taking NNC0174-0833, liraglutide
and "dummy" medicine, from the start to the end of the study. As well as taking the medicine,
participants will have talks with study staff about healthy food choices, how to be more
physically active and what participants can do to lose weight. Participants will either take
NNC0174-0833, liraglutide or "dummy" medicine - which treatment participants get is decided
by chance. Participants will need to take one injection once a week or once a day, depending
on the treatment. The study medicine is injected with a thin needle in a skin fold in the
stomach, thigh or upper arm. The study will last for about 8 months. Participants will have
12 clinic visits with the study doctor.